Molecular mechanism underlying miR‑130b‑Sp1 transcriptional regulation in LPS‑induced upregulation of MUC5AC in the bile duct epithelium

Wu,Xiaodong; Yao,Chenhui; Kong,Jing; Tian,Yu; Fan,Ying; Zhang,Zhen; Han,Jinyan; Wu,Shuodong

doi:10.3892/mmr.2020.11745

Molecular mechanism underlying miR‑130b‑Sp1 transcriptional regulation in LPS‑induced upregulation of MUC5AC in the bile duct epithelium

Authors:
- Xiaodong Wu
- Chenhui Yao
- Jing Kong
- Yu Tian
- Ying Fan
- Zhen Zhang
- Jinyan Han
- Shuodong Wu
View Affiliations

Affiliations: Department of Secondary General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, P.R. China
Published online on: December 1, 2020 https://doi.org/10.3892/mmr.2020.11745
Article Number: 106
Copyright: © Wu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hepatolithiasis is a common disease that represents a serious health threat to the Chinese population. The pathological mechanism underlying hepatolithiasis is closely related to bacterial infections of the intrahepatic bile duct, followed by chronic inflammation and the overexpression of mucin 5AC (MUC5AC). However, the exact mechanism responsible for the lipopolysaccharide (LPS)‑induced upregulation of MUC5AC has yet to be elucidated. Specificity protein 1 (Sp1) is a ubiquitous transcription factor that plays a vital role in the regulation of a number of genes that are responsible for normal cellular function. microRNA (miR/miRNA)‑130b is a member of the miRNA family. miRNAs can bind to the 3'‑untralsated region (3'‑UTR) of a target gene and influence its expression levels. The present study found that LPS increases the expression of MUC5AC by influencing Sp1 secretion. Chromatin immunoprecipitation‑quantitative PCR experiments further verified three Sp1 binding sites in the MUC5AC promoter sequence that can regulate the expression of MUC5AC. Further analysis demonstrated that Sp1 expression was regulated by miR‑130b. Luciferase experiments identified one miR‑130b binding site in the Sp1 3'‑UTR region. In vivo experiments also confirmed the role of the miR‑130b‑Sp1‑MUC5AC signaling pathway in the formation of biliary stones and indicated that this pathway may provide targeted therapeutic strategies for the treatment of intrahepatic bile duct stones.

View Figures

View References

1	Kim HJ, Kim JS, Joo MK, Lee BJ, Kim JH, Yeon JE, Park JJ, Byun KS and Bak YT: Hepatolithiasis and intrahepatic cholangiocarcinoma: A review. World J Gastroenterol. 21:13418–13431. 2015. View Article : Google Scholar
2	Kim HJ, Kim SH, Chae GB, Lee SJ and Kang CD: Increased expression of mucin 5AC mRNA and decreased expression of epidermal growth-factor receptor mRNA in gallstone patients. Tohoku J Exp Med. 214:139–144. 2008. View Article : Google Scholar
3	Wu SD, Yu H and Sun JM: Bacteriological and electron microscopic examination of primary intrahepatic stones. Hepatobiliary Pancreat Dis Int. 5:228–231. 2006.
4	Yoo KS, Choi HS, Jun DW, Lee HL, Lee OY, Yoon BC, Lee KG, Paik SS, Kim YS and Lee J: MUC Expression in gallbladder epithelial tissues in cholesterol-associated gallbladder disease. Gut Liver. 10:851–858. 2016. View Article : Google Scholar
5	Chuang SC, His E and Lee KT: Mucin genes in gallstone disease. Clin Chim Acta. 413:1466–1471. 2012. View Article : Google Scholar
6	Li M, Tian Y, Wu S, Yu H and Li Y: LPS stimulates MUC5AC expression in human biliary epithelial cells: Whether there exists a possible pathway of PKC/NADPH/ROS? Mol Cell Biochem. 385:87–93. 2014. View Article : Google Scholar
7	Tan NY and Khachigian LM: Sp1 phosphorylation and its regulation of gene transcription. Mol Cell Biol. 29:2483–2488. 2009. View Article : Google Scholar
8	Baños-Lara Mdel R, Piao B and Guerrero-Plata A: Differential mucin expression by respiratory syncytial virus and human metapneumovirus infection in human epithelial cells. Mediators Inflamm. 2015:3472922015.
9	Zen Y, Harada K, Sasaki M, Tsuneyama K, Katayanagi K, Yamamoto Y and Nakanuma Y: Lipopolysaccharide induces overexpression of MUC2 and MUC5AC in cultured biliary epithelial cells: Possible key phenomenon of hepatolithiasis. Am J Pathol. 161:1475–1484. 2002. View Article : Google Scholar
10	Vilkin A, Nudelman I, Morgenstern S, Geller A, Dayan YB, Levi Z, Rodionov G, Hardy B, Konikoff F, Gobbic D and Niv Y: Gallbladder inflammation is associated with increase in mucin expression and pigmented stone formation. Dig Dis Sci. 52:1613–1620. 2007. View Article : Google Scholar
11	Corfield AP, Myerscough N, Longman R, Sylvester P, Arul S and Pignatelli M: Mucins and mucosal protection in the gastrointestinal tract: New prospects for mucins in the pathology of gastrointestinal disease. Gut. 47:589–594. 2000. View Article : Google Scholar
12	Ma J, Rubin BK and Voynow JA: Mucins, mucus and goblet cells. Chest. 154:169–176. 2017. View Article : Google Scholar
13	Ali MS and Pearson JP: Upper airway mucin gene expression: A review. Laryngoscope. 117:932–938. 2010. View Article : Google Scholar
14	Rose MC and Voynow JA: Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol Rev. 86:245–278. 2006. View Article : Google Scholar
15	Hewson CA, Edbrooke MR and Johnston SL: PMA induces the MUC5AC respiratory mucin in human bronchial epithelial cells, via PKC, EGF/TGF-alpha, Ras/Raf, MEK, ERK and Sp-1-dependent mechanisms. J Mol Biol. 344:683–695. 2004. View Article : Google Scholar
16	Huang C and Xie K: Crosstalk of Sp1 and Stat3 signaling in pancreatic cancer pathogenesis. Cytokine Growth Factor Rev. 23:25–35. 2012. View Article : Google Scholar
17	Jiang W, Jin Z, Zhou F, Cui J and Wang L and Wang L: High co-expression of Sp1 and HER-2 is correlated with poor prognosis of gastric cancer patients. Surg Oncol. 24:220–225. 2015. View Article : Google Scholar
18	Di YP, Zhao J and Harper R: Cigarette smoke induces MUC5AC protein expression through the activation of Sp1. J Biol Chem. 287:27948–27958. 2012. View Article : Google Scholar
19	Oyanagi T, Takizawa T, Aizawa A, Solongo O, Yagi H, Nishida Y, Koyama H, Saitoh A and Arakawa H: Suppression of MUC5AC expression in human bronchial epithelial cells by interferon-γ. Allergol Int. 66:75–82. 2016. View Article : Google Scholar
20	Aslam F, Palumbo L, Augenlicht LH and Velcich A: The Sp family of transcription factors in the regulation of the human and mouse MUC2 gene promoters. Cancer Res. 61:570–576. 2001.
21	Luke B and David E: Airway mucus and asthma: The role of MUC5AC and MUC5B. J Clin Med. 6:1122017. View Article : Google Scholar
22	Zheng H, Dong X, Liu N, Xia W, Zhou L and Chen X, Yang Z and Chen X: Regulation and mechanism of mouse miR-130a/b in metabolism-related inflammation. Int J Biochem Cell Biol. 74:72–83. 2016. View Article : Google Scholar
23	Li L, Gao F, Jiang Y, Yu L, Zhou Y, Zheng H, Tong W, Yang S, Xia T, Qu Z and Tong G: Cellular miR-130b inhibits replication of porcine reproductive and respiratory syndrome virus in vitro and in vivo. Sci Rep. 5:170102015. View Article : Google Scholar
24	Kaur K, Bhatia H and Datta M: MicroRNAs in hepatic pathophysiology in diabetes. World J Diabetes. 2:158–163. 2011. View Article : Google Scholar
25	Contreras J and Rao DS: MicroRNAs in inflammation and immune responses. Leukemia. 26:404–413. 2012. View Article : Google Scholar
26	Kim C, Lee H, Cho YM, Kwon OJ, Kim W and Lee EK: TNFalpha-induced miR-130 resulted in adipocyte dysfunction during obesity-related inflammation. FEBS Lett. 587:3853–3858. 2013. View Article : Google Scholar
27	Tazuma S, Unno M, Igarashi Y, Inui K, Uchiyama K, Kai M, Tsuyuguchi T, Maguchi H, Mori T, Yamaguchi K, et al: Evidence-based clinical practice guidelines for cholelithiasis 2016. J Gastroenterol. 52:276–300. 2017. View Article : Google Scholar